Published in J Clin Microbiol on November 01, 1985
Comparison of Directigen FLU-A with viral isolation and direct immunofluorescence for the rapid detection and identification of influenza A virus. J Clin Microbiol (1991) 2.66
Rapid detection of influenza virus by shell vial assay with monoclonal antibodies. J Clin Microbiol (1986) 2.31
Evaluation of a monoclonal antibody pool for rapid diagnosis of respiratory viral infections. J Clin Microbiol (1989) 1.69
Rapid diagnosis of influenza A and B by 24-h fluorescent focus assays. J Clin Microbiol (1988) 1.57
Time-resolved fluoroimmunoassay with monoclonal antibodies for rapid diagnosis of influenza infections. J Clin Microbiol (1986) 1.56
Detection of influenza virus by centrifugal inoculation of MDCK cells and staining with monoclonal antibodies. J Clin Microbiol (1989) 1.33
Direct detection of influenza virus antigen in nasopharyngeal specimens by direct enzyme immunoassay in comparison with quantitating virus shedding. J Clin Microbiol (1992) 1.33
Rapid detection of respiratory syncytial virus and influenza A virus in cell cultures by immunoperoxidase staining with monoclonal antibodies. J Clin Microbiol (1990) 1.29
Application of subtype-specific monoclonal antibodies for rapid detection and identification of influenza A and B viruses. J Clin Microbiol (1998) 1.13
Rapid determination of neutralizing antibodies to Semliki Forest virus in serum by enzyme immunoassay in cell culture with virus-specific monoclonal antibodies. J Clin Microbiol (1986) 1.00
Rapid viral diagnosis in perspective. BMJ (1990) 0.85
Diagnosis of influenza A virus infections by detection of specific immunoglobulins M, A, and G in serum. J Clin Microbiol (1989) 0.75
Comparison of direct immunofluorescent staining of clinical specimens for respiratory virus antigens with conventional isolation techniques. J Clin Microbiol (1980) 3.94
Rapid diagnosis of human influenza infection from nasal smears by means of fluorescein-labeled antibody. Proc Soc Exp Biol Med (1957) 3.37
Rapid diagnosis of influenza A infection by direct immunofluorescence of nasopharyngeal aspirates in adults. J Clin Microbiol (1979) 2.95
Monoclonal antibodies for rapid, strain-specific identification of influenza virus isolates. J Clin Microbiol (1982) 1.89
The natural history of congestive heart failure: the Framingham study. N Engl J Med (1971) 13.94
Density difference of DNA of human herpes simplex viruses, types I and II. Virology (1968) 4.03
Type 1 and type 2 herpes simplex viruses: serological and biological differences. J Virol (1970) 3.21
Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med (1972) 2.91
Comparative studies of type 1 and type 2 & 'herpes simplex' viruses. Br J Exp Pathol (1968) 2.56
Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin. J Biol Chem (1973) 2.45
Subunit structure of human fibrinogen, soluble fibrin, and cross-linked insoluble fibrin. Proc Natl Acad Sci U S A (1970) 2.24
All-D-magainin: chirality, antimicrobial activity and proteolytic resistance. FEBS Lett (1990) 2.05
Patterns of cytomegaloviral complement-fixing antibody activity: a longitudinal study of blood donors. J Infect Dis (1973) 1.78
Isolation of viruses from specimens submitted for direct immunofluorescence test for respiratory syncytial virus. J Pediatr (1986) 1.78
Use of a ribosomal RNA gene probe for the epidemiological study of methicillin and ciprofloxacin resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (1990) 1.65
Comparison of rapid immunofluorescence procedure with TestPack RSV and Directigen FLU-A for diagnosis of respiratory syncytial virus and influenza A virus. J Clin Microbiol (1995) 1.59
Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure. J Clin Invest (1976) 1.56
Substructure of human von Willebrand factor. J Clin Invest (1985) 1.55
Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets. J Clin Invest (1979) 1.55
The binding of human plasminogen to fibrin and fibrinogen. J Biol Chem (1983) 1.53
Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor α2-antiplasmin. J Thromb Haemost (2011) 1.51
Analysis of antigenic diversity among human cytomegaloviruses by kinetic neutralization tests with high-titered rabbit antisera. Infect Immun (1978) 1.48
Measles spread in medical settings: an important focus of disease transmission? Pediatrics (1987) 1.48
Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor protein. J Biol Chem (1977) 1.47
The subunit structure of normal and hemophilic factor VIII. J Clin Invest (1973) 1.46
The effect of plasmin on the subunit structure of human fibrinogen. J Biol Chem (1972) 1.44
The diagnostic and therapeutic approach to acute bronchiolitis in hospitalized children in Israel: a nationwide survey. Isr Med Assoc J (2000) 1.40
A survey of current Israeli practices and approach to partially treated meningitis in children. Isr J Med Sci (1995) 1.39
The subunit structures of human plasma and platelet factor XIII (fibrin-stabilizing factor). J Biol Chem (1971) 1.30
Augmentation of the antibacterial activity of magainin by positive-charge chain extension. Antimicrob Agents Chemother (1992) 1.25
The subunit polypeptides of human fibrinogen. Arch Biochem Biophys (1966) 1.24
Pertussis epidemic in Oklahoma. Difficulties in preventing transmission. Am J Dis Child (1986) 1.23
The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis. Ann Intern Med (1998) 1.23
Detection of multiple viral agents in nasopharyngeal specimens yielding respiratory syncytial virus (RSV). An assessment of diagnostic strategy and clinical significance. Diagn Microbiol Infect Dis (1990) 1.22
The effect of fibrin-stabilizing factor on the subunit structure of human fibrin. J Clin Invest (1971) 1.22
Carbohydrate composition and identification of blood group A, B, and H oligosaccharide structures on human Factor VIII/von Willebrand factor. J Biol Chem (1979) 1.21
Spurious hypertension in the obese patient. Effect of sphygmomanometer cuff size on prevalence of hypertension. Arch Intern Med (1984) 1.20
Isolation and characterization of a naturally occurring parainfluenza 3 virus variant. J Clin Microbiol (1995) 1.16
Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. Eur Respir J (2005) 1.14
Pharmacokinetics of single-dose oral ciprofloxacin in patients undergoing chronic ambulatory peritoneal dialysis. Antimicrob Agents Chemother (1986) 1.12
In vitro antibacterial activities of antibiotics against Pseudomonas aeruginosa in peritoneal dialysis fluid. Antimicrob Agents Chemother (1985) 1.12
Production of monoclonal antibodies against parainfluenza 3 virus and their use in diagnosis by immunofluorescence. J Clin Microbiol (1985) 1.11
Partial characterization of a soluble antigen preparation from cells infected with human cytomegalovirus: properties of antisera prepared to the antigen. J Immunol (1975) 1.11
Three-day assay for human cytomegalovirus applicable to serum neutralization tests. Appl Microbiol (1973) 1.09
Molecular structural studies of human factor VIII. Ann N Y Acad Sci (1975) 1.08
Natural infection of dogs on Cape Cod with Rickettsia rickettsii. J Clin Microbiol (1979) 1.07
Blastogenic response of human lymphocytes to human cytomegalovirus. Clin Exp Immunol (1977) 1.05
Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults. J Infect Dis (1987) 1.04
Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo. J Clin Invest (1985) 1.03
The effect of plasmin on the subunit structure of human fibrin. J Biol Chem (1973) 1.03
Serological cross-reaction and cross-protection in guinea pigs infected with Rickettsia rickettsii and Rickettsia montana. Infect Immun (1980) 1.02
Structure-function studies of amphiphilic antibacterial peptides. J Med Chem (1993) 1.02
Community outbreak of adenovirus type 7a infections associated with a swimming pool. South Med J (1987) 1.02
Substructure of human von Willebrand factor. Proteolysis by V8 and characterization of two functional domains. J Biol Chem (1986) 0.99
Cervical excretion cytomegalovirus: correlation with secretory and humoral antibody. J Infect Dis (1977) 0.99
Q fever endocarditis in Israel and a worldwide review. Scand J Infect Dis (1997) 0.99
Comparison of two enzyme-linked immunosorbent assay (EIA) kits with immunofluorescence and isolation in cell culture for detection of respiratory syncytial virus (RSV). Diagn Microbiol Infect Dis (1987) 0.98
Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect. Clin Infect Dis (2004) 0.97
Activation of human plasminogen by urokinase. Partial characterization of a pre-activation peptide. J Biol Chem (1974) 0.96
Effect of intravenous immune globulin on natural killer cell activity: possible association with autoimmune neutropenia and idiopathic thrombocytopenia. J Pediatr (1986) 0.96
Aerosolized ribavirin treatment of respiratory syncytial virus infection in infants hospitalized during an epidemic. Pediatr Infect Dis J (1987) 0.95
Activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2. Int J Pept Protein Res (1994) 0.94
Spotted fever group rickettsiae in Dermacentor variabilis from Cape Cod, Massachusetts. Am J Trop Med Hyg (1980) 0.94
The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity. J Biol Chem (1983) 0.92
Molecular biology of factor VIII/von Willebrand Factor. Thromb Haemost (1978) 0.92
Carbohydrate on human factor VIII/von Willebrand factor. Impairment of function by removal of specific galactose residues. J Biol Chem (1978) 0.92
Enhanced repopulation of murine hematopoietic organs in sublethally irradiated mice after treatment with ciprofloxacin. Blood (1991) 0.91
Effect of protease binding by alpha 2-macroglobulin on intrinsic fluorescence. Biochemistry (1982) 0.91
Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation. Proc Natl Acad Sci U S A (1979) 0.91
Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin. J Clin Invest (1972) 0.91
Cross-linking of wild-type and mutant alpha 2-antiplasmins to fibrin by activated factor XIII and by a tissue transglutaminase. J Biol Chem (2000) 0.90
Synergistic action of amphotericin B and rifampin against Rhizopus species. Antimicrob Agents Chemother (1987) 0.90
Subunit structure of fragment D from fibrinogen and cross-linked fibrin. J Biol Chem (1973) 0.90
Factor VIII/von Willebrand protein. Modification of its carbohydrate causes reduced binding to platelets. J Biol Chem (1980) 0.89
Electron microscopy of human factor VIII/Von Willebrand glycoprotein: effect of reducing reagents on structure and function. J Cell Biol (1982) 0.88
Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis. Am J Med (1987) 0.88
The importance of the preactivation peptide in the two-stage mechanism of human plasminogen activation. J Biol Chem (1975) 0.88
Human rotavirus-like particles in a hepatic abscess. J Pediatr (1985) 0.87
Structural and functional characterization of the inhibition of urokinase by alpha 2-macroglobulin. Biochemistry (1985) 0.87
Maternal and fetal serum and tissue levels of ceftriaxone following preoperative prophylaxis in emergency cesarean section. Chemotherapy (1993) 0.87
Antibody reactivity to human and vervet cytomegalovirus early antigen(s) in sera from patients with active cytomegalovirus infections and from asymptomatic donors. J Clin Microbiol (1979) 0.86
Reactions of thrombin with human factor VIII/von Willebrande factor protein. J Biol Chem (1980) 0.86
Behavior of human cytomegaloviruses in cell cultures of bovine and simian origin. Proc Soc Exp Biol Med (1974) 0.86
Electron microsocpy of plasmic fragments of human fibrinogen as related to trinodular structure of the intact molecule. J Clin Invest (1980) 0.86
Effects of the spleen on canine factor VIII levels. J Lab Clin Med (1970) 0.86
Risk factors for sternal wound infection in children undergoing cardiac surgery: a case-control study. J Hosp Infect (2008) 0.85
Evidence that alpha2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation. J Thromb Haemost (2008) 0.85
Single-dose pharmacokinetics of imipenem-cilastatin in pediatric patients. Pediatr Pharmacol (New York) (1986) 0.85
Cross-linking of fibrin by fibrin=stabilizing factor. Ann N Y Acad Sci (1972) 0.85
A re-examination of the cleavage of fibrinogen and fibrin by plasmin. J Biol Chem (1975) 0.84
Predictive value of compression ultrasonography for deep vein thrombosis in symptomatic outpatients: clinical implications of the site of vein noncompressibility. Arch Intern Med (2000) 0.84
Pharmacokinetics of two dosage regimens of ciprofloxacin during a two-week therapeutic trial in patients with cystic fibrosis. Am J Med (1987) 0.84
BP control. Improvement in a university medical clinic by use of a physician's associate. Arch Intern Med (1983) 0.84
Moxifloxacin enhances antiproliferative and apoptotic effects of etoposide but inhibits its proinflammatory effects in THP-1 and Jurkat cells. Br J Cancer (2006) 0.83
Localization of the alpha-chain cross-link acceptor sites of human fibrin. J Biol Chem (1978) 0.83
Observations on structure-function relationships of human antihemophilic/von Willebrand factor protein. Ann N Y Acad Sci (1981) 0.83
Natural killing (NK) of cytomegalovirus (CMV)-infected fibroblasts: a comparison between two strains of CMV, uninfected fibroblasts, and K562 cells. J Med Virol (1985) 0.83
Why alpha-antiplasmin must be converted to a derivative form for optimal function. J Thromb Haemost (2007) 0.83
Survival of patients with congestive heart failure. N Engl J Med (1972) 0.82
Is there a precursive, relatively procoagulant-inactive form of normal antihemophilic factor (factor VIII)? Blood (1979) 0.82
The inhibitory effect of ciprofloxacin on proliferation of a murine bladder carcinoma cell line. J Antimicrob Chemother (1992) 0.82
Destruction of factor VIII procoagulant activity in tissue culture media. Blood (1978) 0.82
Differential diagnoses of influenza A virus, influenza B virus, and respiratory syncytial virus infections by direct immunofluorescence using mixtures of monoclonal antibodies of different isotypes. J Clin Microbiol (1996) 0.81
Predictions of coronary artery stenosis by artificial neural network. Artif Intell Med (2000) 0.81